Jul 5, 2018
This report focuses on the Rivaroxaban in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report also categorizes the market based on manufacturers, regions, type and application.

Pune, India - July 4, 2018 /MarketersMedia/ —
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
Market share of global Rivaroxaban industry is dominate by companies like Bayer, J&J and others which are profiled in this report as well in terms of Sales, Price, Revenue, Gross Margin and Market Share (2017-2019).
Access Report Details at: https://www.themarketreports.com/report/global-rivaroxaban-market-by-manufacturers-regions-type-and-application-forecast-to-2023
There are 15 Chapters to deeply display the global Rivaroxaban market.
Chapter 1, to describe Rivaroxaban Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Rivaroxaban, with sales, revenue, and price of Rivaroxaban, in 2017 and 2018;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Rivaroxaban, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Rivaroxaban market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Rivaroxaban sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Purchase this premium research report at: https://www.themarketreports.com/report/buy-now/1204292
Market Segment by Regions, regional analysis covers:
• North America (USA, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Columbia, etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers:
• 2.5 mg
• 10 mg
• 15 mg
• 20 mg
Market Segment by Applications, can be divided into
• Acute Coronary Syndrome (ACS)
• Venous Thromboembolism (VTE)
Ask your report related queries at: https://www.themarketreports.com/report/ask-your-query/1204292
Contact Info:
Name: Shirish Gupta
Email: [email protected]
Organization: The Market Reports
Address: SF-29, North Block, Sacred World, Wanawadi
Phone: +1-631-407-1315
For more information, please visit https://www.themarketreports.com/report/global-rivaroxaban-market-by-manufacturers-regions-type-and-application-forecast-to-2023
Source: MarketersMedia
Release ID: 372526
Eternal's Deepinder Goyal responded to questions about his wearable device, Temple, emphasising its secure adhesive Grips and comfort. Users can wear it during various activities, including showering, with a recommended Grip replacement every two to three days, he said.
It is hoped the prospective sale provides a haven for wildlife in an urban area.
India needs its own AI safety framework, not a copy of US pact: Industry experts
Six awards will be announced this week in science, literature, economics and peace work.
Small particulates sent up by wildfires are a well-documented health hazard. But recent research finds that ground-level ozone is now on the rise, too.
A huge debate has erupted on X (formerly Twitter) over how often you need to wash your clothes.
Leading AI researchers are now sounding the alarm over the growing threat of 'enfeeblement'.
AI has remarkable potential to exponentially advance scientific discovery, say scientists. But getting out the word of its scientific benefits of can be challenging when forced to compete with headlines about its significant if not existential threat to humanity.
A suspected member of the ShinyHunters digital extortion group, who goes by the online alias "Rey," has been allegedly detained by authorities in Jordan, Reuters reported, citing three people familiar with the matter. Rey, whose real name is Saif al-Din Khader, is said to have been brought into custody on September 29, 2026, cooperating with the U.S. Federal Bureau of Investigation (FBI) and
A new China-nexus cyber espionage group known as TA419 has been attributed to multiple credential phishing campaigns targeting artificial intelligence (AI) experts working for U.S. think tanks, universities, and legal sector organizations. The campaigns have impersonated prominent economists and AI policymakers, as well as a prominent Anthropic employee, to single out an AI policy expert at a
A National Trust manager says recent summers have "brought home" the impact of climate change.
The Internet Freedom Foundation's (IFF) statement came after Jack Dorsey said Apple removed Bitchat from the India App Store following a takedown demand from the Ministry of Electronics and Information Technology (MeitY).
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.